Successful treatment of meningitis caused by highly-penicillin-resistant Streptococcus mitis in a leukemic child

Tang-Her Jaing1, Cheng-Hsun Chiu, Iou-Jih Hung

  • 1Department of Pediatrics, Chang Gung Children's Hospital, Taipei.

Insights

Viridans streptococci, particularly Streptococcus mitis, can cause severe infections in neutropenic cancer patients. This case highlights successful treatment of S. mitis meningitis in a child with leukemia, even with antibiotic resistance.

Area of Science:

  • Infectious Diseases
  • Oncology
  • Microbiology

Background:

  • Viridans streptococci are increasingly implicated in infections among neutropenic cancer patients.
  • Streptococcus mitis exhibits high resistance to beta-lactam antibiotics within this group.
  • Bacterial meningitis without cerebrospinal fluid (CSF) pleocytosis is a rare and diagnostically challenging presentation.

Observation:

  • A 6-year-old boy with leukemia and neutropenia developed sepsis and meningitis.
  • The causative agent was identified as Streptococcus mitis with high-level resistance to penicillin and cephalosporins.
  • The patient presented with meningeal signs despite the absence of CSF pleocytosis.

Findings:

  • Successful treatment was achieved using a combination of vancomycin, ceftriaxone, and granulocyte-colony-stimulating factor.
  • The patient, who received trimethoprim-sulfamethoxazole prophylaxis, experienced a long-term survival.
  • This case underscores the importance of considering bacterial meningitis in neutropenic patients with meningeal signs, irrespective of CSF findings.

Implications:

  • Highlights the potential for antibiotic-resistant S. mitis in immunocompromised hosts.
  • Emphasizes the need for vigilance in diagnosing meningitis in neutropenic patients, even with atypical CSF profiles.
  • Demonstrates a viable therapeutic strategy involving combination therapy and supportive care for challenging S. mitis infections.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...